Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Market Cap (22-Oct) $21,608,652 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (19-Oct) 1,858,764 (0.34%) (355th)
52w High $0.430	52w Low $0.032	P/E 13.30	EPS -0.32

Short Interest

ASIC data, 19 Oct 2026

% Shorted

0.34% 0.03

vs 0.31% prior report

Most Shorted Rank

355th

of 703 shorted ASX stocks

Peak Short

8.10%

Aug 2023

Days to Cover

0.6

at 50d avg vol

View full short position history →

	Subject
	IMU IMU Ann: FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC
	1 (current) 2 3
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Notice of Annual General Meeting/Proxy Form
	IMU IMU Ann: Change of Director's Interest Notice - LR
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Investor Presentation
	IMU IMU Ann: Corporate Governance Statement
	IMU IMU Ann: Appendix 4G
	IMU IMU Ann: Annual Report to shareholders
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Imugene HER-Vaxx Immunotherapy Patent Granted in Japan
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Becoming a substantial holder - PH
	IMU IMU Ann: Change of Director's Interest Notice - PH
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Proposed issue of securities - IMU
	IMU IMU Ann: Results of Meeting
	IMU IMU Ann: S&P DJI Announces September 2021 Quarterly Rebalance
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials
	IMU IMU Ann: Appendix 4E and Full Year Statutory Accounts
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx
	IMU IMU Ann: Response to ASX Query
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Results of Share Purchase Plan
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Further Information on Partnership with Celularity
	IMU IMU Ann: Notice of Extraordinary General Meeting/Proxy Form
	IMU IMU Ann: Imugene Investor Webinar with Celularity Dr Robert Hariri
	IMU IMU Ann: Investor Presentation
	IMU IMU Ann: Research partnership with Celularity for solid tumors
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Imugene to present at NWR virtual investor conference
	IMU IMU Ann: Prospectus for SPP and Placement Options Offer
	IMU IMU Ann: Proposed issue of securities - IMU
	IMU IMU Ann: Proposed issue of securities - IMU
	IMU IMU Ann: Imugene Capital Raising Presentation
	IMU IMU Ann: Imugene completes $90 M placement and launches $5 M SPP
	IMU IMU Ann: Investor Webinar
	IMU IMU Ann: Trading Halt
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Appendix 4C - Quarterly Report
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of securities - IMU

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
22-Oct	$0.04	2,102,517	+0.00 (5.41%)
21-Oct	$0.04	4,194,902	+0.00 (2.78%)
20-Oct	$0.04	3,509,307	+0.00 (5.88%)
19-Oct	$0.03	8,242,493	0.00 (5.56%)
16-Oct	$0.04	2,269,661	+0.00 (5.88%)
15-Oct	$0.03	3,119,300	0.00 (5.56%)
14-Oct	$0.04	1,098,831	0.00 (2.70%)
13-Oct	$0.04	4,012,027	0.00 (5.13%)
12-Oct	$0.04	1,953,196	0.00 (0.00%)
09-Oct	$0.04	1,833,594	0.00 (7.14%)
08-Oct	$0.04	2,315,349	+0.00 (2.44%)
07-Oct	$0.04	4,284,215	0.00 (0.00%)
06-Oct	$0.04	3,986,611	0.00 (4.65%)
05-Oct	$0.04	19,537,971	+0.01 (16.22%)
02-Oct	$0.04	5,400,451	0.00 (5.13%)
6 up, 7 down, and 2 flat days

Imugene Health Care
Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy